Skip to main content
Fig. 5 | BMC Public Health

Fig. 5

From: Systematic literature review of the impact and effectiveness of monovalent meningococcal C conjugated vaccines when used in routine immunization programs

Fig. 5

Impact of MCCV program in other countries (Incidence rate reduction comparing pre-and-post-vaccination periods). Australia: MCCVintroduced in 2003 (at 12 months of age); Belgium: MCCV introduced in 2002 (at 12–15 months of age); Canada: MCCV introduced in 2001–2005 (at 2, 4, 6 months of age); Italy MCCV program introduced in the NIP in 2000 (2, 4, 6 months of age)

Back to article page

BMC Public Health

ISSN: 1471-2458

Contact us